Among them, CASC19 upregulation has been reported to be associated with poor prognosis in GC and was an independent prognostic factor for overall survival, while silencing CASC19 inhibits proliferation and migration of GC cell (Wang et al., 2019). This evidence concerns the gene CASC19 and gastric cancer.